Literature DB >> 27693002

The role of miRNAs in cardiovascular disease risk factors.

Joy N Jones Buie1, Andrew J Goodwin2, James A Cook3, Perry V Halushka4, Hongkuan Fan5.   

Abstract

Coronary artery disease and atherosclerosis are complex pathologies that develop over time due to genetic and environmental factors. Differential expression of miRNAs has been identified in patients with coronary artery disease and atherosclerosis, however, their association with cardiovascular disease risk factors, including hyperlipidemia, hypertension, obesity, diabetes, lack of physical activity and smoking, remains unclear. This review examines the role of miRNAs as either biomarkers or potential contributors to the pathophysiology of these aforementioned risk factors. It is intended to provide an overview of the published literature which describes alterations in miRNA levels in both human and animal studies of cardiovascular risk factors and when known, the possible mechanism by which these miRNAs may exert either beneficial or deleterious effects. The intent of this review is engage clinical, translational, and basic scientists to design future collaborative studies to further elucidate the potential role of miRNAs in cardiovascular diseases.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Coronary artery disease; Review; Risk factors; miRNA

Mesh:

Substances:

Year:  2016        PMID: 27693002      PMCID: PMC5125538          DOI: 10.1016/j.atherosclerosis.2016.09.067

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  146 in total

1.  Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Tatiana Nwankwo; Sung Sug Yoon; Vicki Burt; Quiping Gu
Journal:  NCHS Data Brief       Date:  2013-10

2.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

Review 3.  MicroRNA Regulation of Atherosclerosis.

Authors:  Mark W Feinberg; Kathryn J Moore
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

4.  Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure.

Authors:  Rusty L Montgomery; Thomas G Hullinger; Hillary M Semus; Brent A Dickinson; Anita G Seto; Joshua M Lynch; Christianna Stack; Paul A Latimer; Eric N Olson; Eva van Rooij
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

Review 5.  MicroRNAs as pharmacological targets in endothelial cell function and dysfunction.

Authors:  Aránzazu Chamorro-Jorganes; Elisa Araldi; Yajaira Suárez
Journal:  Pharmacol Res       Date:  2013-04-18       Impact factor: 7.658

Review 6.  Targeting microRNAs in obesity.

Authors:  Huangming Xie; Lei Sun; Harvey F Lodish
Journal:  Expert Opin Ther Targets       Date:  2009-10       Impact factor: 6.902

Review 7.  microRNAs in lipoprotein metabolism and cardiometabolic disorders.

Authors:  Noemi Rotllan; Nathan Price; Paramita Pati; Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Atherosclerosis       Date:  2016-01-18       Impact factor: 5.162

8.  Why choice of metric matters in public health analyses: a case study of the attribution of credit for the decline in coronary heart disease mortality in the US and other populations.

Authors:  Hebe N Gouda; Julia Critchley; John Powles; Simon Capewell
Journal:  BMC Public Health       Date:  2012-01-28       Impact factor: 3.295

9.  The miRNA plasma signature in response to acute aerobic exercise and endurance training.

Authors:  Søren Nielsen; Thorbjörn Åkerström; Anders Rinnov; Christina Yfanti; Camilla Scheele; Bente K Pedersen; Matthew J Laye
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

10.  TCF2 attenuates FFA-induced damage in islet β-cells by regulating production of insulin and ROS.

Authors:  Xiaojuan Quan; Lin Zhang; Yingna Li; Chunlian Liang
Journal:  Int J Mol Sci       Date:  2014-07-30       Impact factor: 5.923

View more
  18 in total

1.  Life-style-induced metabolic derangement and epigenetic changes promote diabetes and oxidative stress leading to NASH and atherosclerosis severity.

Authors:  Rai Ajit K Srivastava
Journal:  J Diabetes Metab Disord       Date:  2018-11-29

2.  The effect of eight weeks of moderate and high intensity aerobic training on the gene expression of Mir-145, Wnt3a and Dab2 in the heart tissue of type 2 diabetic rats.

Authors:  Sahar Rezaei; Asieh Abbassi Daloii; Alireza Barari; Mozhgan Ahmadi
Journal:  J Diabetes Metab Disord       Date:  2021-10-16

3.  Plasma circulating microRNAs in patients with stable coronary artery disease - Impact of different cardiovascular risk profiles and glomerular filtration rates.

Authors:  Karlis Trusinskis; Maris Lapsovs; Sandra Paeglite; Evija Knoka; Laima Caunite; Mairita Mazule; Ieva Briede; Sanda Jegere; Indulis Kumsars; Inga Narbute; Ilze Konrade; Andrejs Erglis; Aivars Lejnieks
Journal:  J Clin Transl Res       Date:  2021-04-16

Review 4.  Novel Modulators of Asthma and Allergy: Exosomes and MicroRNAs.

Authors:  Beatriz Sastre; José A Cañas; José M Rodrigo-Muñoz; Victoria Del Pozo
Journal:  Front Immunol       Date:  2017-07-21       Impact factor: 7.561

Review 5.  RNAi therapy to the wall of arteries and veins: anatomical, physiologic, and pharmacological considerations.

Authors:  Christoph S Nabzdyk; Leena Pradhan-Nabzdyk; Frank W LoGerfo
Journal:  J Transl Med       Date:  2017-07-28       Impact factor: 5.531

Review 6.  Novel Immune Mechanisms in Hypertension and Cardiovascular Risk.

Authors:  Ryszard Nosalski; Eilidh McGinnigle; Mateusz Siedlinski; Tomasz J Guzik
Journal:  Curr Cardiovasc Risk Rep       Date:  2017-03-06

Review 7.  Cardiovascular disease-related miRNAs expression: potential role as biomarkers and effects of training exercise.

Authors:  Simona Ultimo; Giorgio Zauli; Alberto M Martelli; Marco Vitale; James A McCubrey; Silvano Capitani; Luca M Neri
Journal:  Oncotarget       Date:  2018-03-30

8.  MicroRNA expression profile during different conditions of hypoxia.

Authors:  Donato Lacedonia; Giulia Scioscia; Grazia Pia Palladino; Crescenzio Gallo; Giovanna Elisiana Carpagnano; Roberto Sabato; Maria Pia Foschino Barbaro
Journal:  Oncotarget       Date:  2018-10-12

9.  Circulating MicroRNAs in Young Patients with Acute Coronary Syndrome.

Authors:  Kind-Leng Tong; Ahmad Syadi Mahmood Zuhdi; Wan Azman Wan Ahmad; Paul M Vanhoutte; Joao Pedro de Magalhaes; Mohd Rais Mustafa; Pooi-Fong Wong
Journal:  Int J Mol Sci       Date:  2018-05-15       Impact factor: 5.923

10.  Thromboangiitis obliterans plasma-derived exosomal miR-223-5p inhibits cell viability and promotes cell apoptosis of human vascular smooth muscle cells by targeting VCAM1.

Authors:  Ying Deng; Jindong Tong; Weijun Shi; Zhongyi Tian; Bo Yu; Jingdong Tang
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.